Exosomal microRNA Panels for Detecting Early-Stage Non-Small Cell Lung Cancer

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Lung cancer diagnosis often relies on invasive lung nodule biopsies, posing risks of severe complications.
• There is a critical need for non-invasive diagnostic methods for early-stage non-small cell lung cancer (NSCLC).

Purpose of the Study:

• To identify and optimize panels of exosomal microRNAs (miRNAs) for the non-invasive diagnosis of early-stage NSCLC.
• To evaluate the diagnostic potential of exosomal miRNAs as biomarkers for lung cancer detection.

Main Methods:

• Utilized a four-phase approach: discovery (next-generation sequencing), validation (qPCR), optimization (up-down ratio platform), and confirmation (bioinformatics).
• Exosomal miRNAs were profiled in serum samples from patients with benign lung nodules and stage-specific NSCLC.
• A novel "up-down ratio (UDR)" platform was developed for miRNA panel optimization.

Main Results:

• Identified and validated six candidate exosomal miRNAs, including miR-150-5p and miR-497-5p.
• The UDR platform identified an optimized four-miRNA panel with a diagnostic accuracy (ROC) exceeding 0.93 for early NSCLC detection.
• Bioinformatics analysis revealed key miRNA-target gene interactions involving VEGFA, BCL2, and PTEN.

Conclusions:

• Exosomal miRNA panels demonstrate significant potential as non-invasive diagnostic biomarkers for early-stage lung cancer.
• The identified four-miRNA panel (miR-150-5p, miR-301b-3p, miR-369-3p, and miR-497-5p) shows promise for clinical application in NSCLC diagnosis.